Test Price
2,800 AED✅ Home Collection Available
SUFU Gene Meningioma Susceptibility Test (NGS) in UAE | 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Genetic Counselling for Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test employs Next-Generation Sequencing (NGS) to analyse the entire coding region of the SUFU gene for germline variants that confer an elevated lifetime risk of meningiomas, often within a familial context. The assay includes detection of copy number variations (CNVs) and is performed on clinically validated Illumina/DNBSEQ platforms to ensure comprehensive coverage and high analytical sensitivity.
| Parameter | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage with CNV detection | 99.99% per base, but limited to targeted exons only |
| Methodology | Massively parallel NGS (Illumina/DNBSEQ), clinically validated | Sanger sequencing, single-amplicon assessment |
| Turnaround Time | 3-4 Weeks | 4-6 Weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) explains: "A genetic test result is not destiny – it is a powerful tool for proactive healthcare. I strongly advise that all patients undergo pre- and post-test genetic counselling; a mutation in SUFU guides surveillance but does not guarantee tumour development. Please never self-interpret; always discuss your results with a qualified oncologist or clinical geneticist to make informed decisions."
Medication Advisory
⚠️ Important Medication Notice
Do not discontinue, alter, or modify any prescribed medication regimen based on genetic test results without explicit consultation with your treating physician. Genetic findings are intended to guide long-term surveillance and risk assessment, not to replace current therapeutic protocols.
Safety & Exclusion Criteria
- Exclusion Criteria: Individuals under 18 years without valid parental/legal guardian consent as per UAE regulatory frameworks; patients unable to provide informed consent for genetic testing; active severe infection that may compromise sample quality.
- Emergency Red Flags – Seek Immediate Medical Attention if you experience: Sudden severe headache, vision loss or double vision, new-onset seizures, progressive weakness or numbness, altered consciousness. These may indicate an active meningioma requiring urgent evaluation.
- Pre-Test Requirement: A mandatory genetic counselling session to construct a pedigree chart documenting family members affected with SUFU-gene-associated meningioma is required before sample collection.
Patient FAQ & Clinical Guidance
1. What is the SUFU gene test and who should consider it?
This DNA test identifies inherited mutations in the SUFU gene that increase lifetime risk of familial meningioma. It is recommended for individuals with a personal or family history of meningiomas, or those with clinical features suggesting Gorlin syndrome or related hereditary tumour predisposition syndromes. Genetic counselling prior to testing is essential to determine appropriateness.
2. How is the sample collected and how long do results take?
A standard peripheral blood draw is performed by our VIP Mobile Phlebotomy team at your home or office, with temperature-controlled cold-chain transport to the laboratory. Results are typically delivered within 3 to 4 weeks from sample receipt. An alternative FTA card collection method is available upon request for remote patients.
3. Will my insurance cover this and is my genetic data kept private?
We offer direct billing verification with most UAE insurance providers via WhatsApp at +971 54 548 8731. Your genetic data is protected under the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are shared only with you and your designated healthcare provider after consent.
4. What happens if my test is positive for a SUFU mutation?
A positive result indicates an increased lifetime risk for meningioma but does not confirm active disease. Your genetic counsellor and consulting physician will discuss tailored surveillance protocols, typically including periodic brain MRI scans, and risk management strategies. Cascade testing for at-risk family members is strongly recommended through a clinical genetics service.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All genetic testing procedures at DNA Labs UAE are conducted in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring your genetic data is collected, processed, and stored with the highest standards of confidentiality and consent management.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure handling of electronic health records and tele-counselling sessions.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – providing the legal framework for pre-test informed consent and post-test clinical accountability.
- DHA Standards for Genetic Testing Services – all testing protocols are reviewed and licensed under Dubai Healthcare City regulatory oversight.
Our laboratory is ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139), affirming our commitment to quality management in diagnostic service delivery.
Clinical & Logistical Metadata
| Test Name | SUFU Gene Meningioma Susceptibility Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or FTA Card; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina/DNBSEQ with CNV Detection |
| ICD-10-CM Code | Z15.09, Z80.0 |
| LOINC Code | 81307-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians